Page last updated: 2024-09-02

fingolimod hydrochloride and Headache

fingolimod hydrochloride has been researched along with Headache in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnold, DL; Banwell, B; Bar-Or, A; Brück, W; Chen, Y; Chitnis, T; Gärtner, J; Ghezzi, A; Giovannoni, G; Greenberg, B; Krupp, L; Merschhemke, M; Putzki, N; Rostásy, K; Stites, T; Tardieu, M; Waubant, E; Wolinsky, JS1
Adoni, T; Fragoso, YD; Gomes, S; Goncalves, MV; Matta, AP; Mendes, MF; Siquineli, F1
Brescia Morra, V; Brogi, D; Comi, G; Guidi, L; Laroni, A; Lugaresi, A; Mancardi, GL; Pozzilli, C; Raimondi, D; Turrini, R; Uccelli, A1
Bermel, RA; Cohen, JA; Hara-Cleaver, C; Ontaneda, D; Rudick, RA1

Reviews

1 review(s) available for fingolimod hydrochloride and Headache

ArticleYear
Oral fingolimod (gilenya) for multiple sclerosis.
    The Medical letter on drugs and therapeutics, 2010, Dec-29, Volume: 52, Issue:1353-1354

    Topics: Administration, Oral; Animals; Fingolimod Hydrochloride; Headache; Humans; Immunosuppressive Agents; Multiple Sclerosis; Propylene Glycols; Randomized Controlled Trials as Topic; Sphingosine

2010

Trials

2 trial(s) available for fingolimod hydrochloride and Headache

ArticleYear
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.
    The New England journal of medicine, 2018, 09-13, Volume: 379, Issue:11

    Topics: Administration, Oral; Adolescent; Brain; Child; Female; Fingolimod Hydrochloride; Headache; Humans; Immunologic Factors; Infections; Injections, Intramuscular; Interferon-beta; Leukopenia; Magnetic Resonance Imaging; Male; Multiple Sclerosis, Relapsing-Remitting; Secondary Prevention

2018
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017, Volume: 38, Issue:1

    Topics: Adult; Female; Fingolimod Hydrochloride; Headache; Humans; Immunosuppressive Agents; Infections; Italy; Macular Edema; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Treatment Outcome

2017

Other Studies

2 other study(ies) available for fingolimod hydrochloride and Headache

ArticleYear
Persistent headache in patients with multiple sclerosis starting treatment with fingolimod.
    Headache, 2015, Volume: 55, Issue:4

    Topics: Adult; Female; Fingolimod Hydrochloride; Headache; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis; Time Factors; Treatment Outcome; Young Adult

2015
Early tolerability and safety of fingolimod in clinical practice.
    Journal of the neurological sciences, 2012, Dec-15, Volume: 323, Issue:1-2

    Topics: Adult; Bradycardia; Chest Pain; Drug Substitution; Female; Fingolimod Hydrochloride; Headache; Humans; Hypertension; Lymphopenia; Macular Edema; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Nausea; Patient Acceptance of Health Care; Product Surveillance, Postmarketing; Propylene Glycols; Retrospective Studies; Sphingosine

2012